SOCS3 and epilepsy: Furthermore, the key cytokine suppressor of cytokine signaling 3 (SOCS3) involved in the transformation of pro‐inflammatory M1 and antiinflammatory M2 microglia54 may provide a research direction for drug therapy targets or adjuvant therapy for patients with epilepsy at high altitude.